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The ``pocket'' protein- and p300-binding domains of E1A mediate alternative pathways that, independently, provoke S
phase reentry in ventricular muscle cells and repress cardiac-speci®c transcription. In the present study, we utilized
recombinant adenovirus to deliver mammalian E2F-1, whose release from pocket proteins may underlie effects of E1A and
mitogenic signaling. Like E1A, E2F-1 proved cytotoxic in the absence of E1B. Used along with E1B to avert apoptosis, E2F-
1 inhibited the cardiac and skeletal a-actin promoters, serum response factor abundance, and sarcomeric actin biosynthesis,
while inducing DNA synthesis and proliferating cell nuclear antigen. Image analysis of Feulgen-stained nuclei corroborated
a parallel increase in DNA content, with accumulation in G2/M. Thus, E2F-1 suf®ces for all observed actions of E1A in
cardiac myocytes. q 1996 Academic Press, Inc.
INTRODUCTION cycle in cardiac muscle (Claycomb and DiNardo, 1995), al-
though numerous disparities with skeletal myocytes are ap-
parent for both sets of events: absence of MyoD, myogenin,A provocative model for the reciprocal linkage between
myf-5, and MRF4 (Olson and Klein, 1994); dissociation ofproliferative growth and tissue-speci®c transcription in
DNA synthesis from cytokinesis in ventricular muscle soonskeletal muscle and certain other lineages proposes a dual
after birth, resulting in polyploid myocytes; divergent ef-role for tumor suppressor ``pocket'' proteinsÐthe retino-
fects of transforming growth factor b or basic ®broblastblastoma gene product, pRb, and its relatives, p107 and p130
growth factor on differentiation of skeletal versus cardiac(Gu et al., 1993; Schneider et al., 1994). In quiescent cells,
muscle (repression versus induction of a ``fetal'' program,the pocket domain binds E2F transcription factors, pre-
respectively) (MassagueÂ et al., 1986; Parker et al., 1990); andventing the induction of genes such as DNA polymerase a,
corresponding differences in transcriptional control by Rasdihydrofolate reductase, and cdc2, required for DNA syn-
(Abdellatif et al., 1994; Payne et al., 1987; Thorburn et al.,thesis (Nevins, 1992). Conversely, binding via the pocket
1993).may confer transcriptional activity to the myogenic deter-
Previously, we tested for the operation of pocket protein-mination protein, MyoD, and other myogenic factors (Gu
dependent pathways that might impinge on cardiac-speci®cet al., 1993; Schneider et al., 1994). Much less is known of
transcription and the cardiac cell cycle, using recombinantmechanisms governing differentiation and exit from the cell
adenoviruses to deliver the adenoviral E1A gene (Kirshen-
baum and Schneider, 1995). E1A shares with SV40 large T
antigen and human papilloma virus E7 the ability to bind1 To whom correspondence should be addressed at Molecular
all members of the pocket protein family and inactivateCardiology Unit, Baylor College of Medicine, One Baylor Plaza,
their function (Moran, 1994). 12S E1A provoked widespreadRoom 506C, Houston, TX 77030. Fax: (713) 798-7437. E-mail:
michaels@bcm.tmc.edu. cell death; apoptosis was alleviated by a second adenoviral
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fection. Constructs driven by the skeletal a-actin, cardiac a-actin,gene, E1B. Using E1B to obviate cell death, 12S E1A selec-
and Herpes simplex virus thymidine kinase promoters were de-tively repressed the transcription of cardiac-restricted pro-
tailed previously (Abdellatif et al., 1994; Brand et al., 1993; Kirshen-moters and provoked reentry into the cell cycle by neonatal
baum and Schneider, 1995). Results were compared by the Student±ventricular myocytes (Kirshenbaum and Schneider, 1995).
Newman±Keuls test for analysis of variance and the unpaired two-Point substitutions within E1A indicated that pocket pro-
tailed t test, using a signi®cance level of P  0.05.
tein binding was suf®cient for these actions, as postulated, Recombinant adenoviruses. Adenoviruses were propagated,
but was dispensable: an alternative pathway mediated by harvested, puri®ed, and titered as described (Kirshenbaum and
the binding site for a bromodomain transcription factor, Schneider, 1995). ``12S E1A / E1B'' denotes virus 12S.WT (Moran
p300, had comparable effects, while an E1A protein that et al., 1986), containing the EcoRI±XbaI fragment of 12S Ad2 E1A
binds neither pocket proteins nor p300 was inactive (Kir- cDNA in Ad5dl309. ``R2G / E1B,'' ``Y47H,C124G / E1B,'' and
``R2G,C124G / E1B'' designate the amino acid substitutions ofshenbaum and Schneider, 1995). Consequently, pocket pro-
12S.RG2, 12S.YH47/928, and 12S.RG2/928 (Wang et al., 1993).tein- and p300-binding sites of E1A each suf®ce, in the ab-
``12S E1A0 E1B'' indicates 12SE1B0, deleting E1B nucleotides 1769sence of the other, for transcriptional repression in cardiac
to 3322 (Chiou et al., 1994). Adenovirus encoding human E2F-cells and reentry into S phase.
1, driven by the cytomegalovirus immediate-early enhancer, wasE1A can bypass the signal transduction cascade for hyper-
kindly provided by J. Nevins (Schwarz et al., 1995). Cells in serum-phosphorylation of pocket proteins, which otherwise would
free medium for 24 hr were infected with recombinant adenovi-
be required for release of free E2F, and thus has been utilized ruses for 6 hr, and then were analyzed after 24±72 hr in the absence
as a surrogate for mitogenic growth factors (Moran, 1994). of serum. Cultures were incubated with 20 plaque-forming units
One challenge to ready interpretation of the pocket protein/ per cell, which achieves gene delivery to⁄95% of neonatal ventric-
p300 modelÐdespite precedent for operation of these dual ular cells under these conditions.
pathways in other lineagesÐis its reliance on viral onco- Immunocytochemistry. DNA synthesis was monitored as in-
corporation of 10 mM 5*-bromodeoxyuridine (BrdU) 44±48 hr afterproteins for which no exact homologue exists in eukaryotic
infection, using mouse monoclonal antibody against BrdU andcells. Some actions of E1A are independent of all character-
horseradish peroxidase-conjugated goat antibody to mouse IgG2aized binding domains, and novel functions have been attrib-
(Pierce) or ¯uorescein-conjugated mouse IgG1 against BrdU (Boeh-uted to the amino terminus (Dorsman et al., 1995). A criti-
ringer Mannheim) (Kirshenbaum and Schneider, 1995). Cardiac myo-cal test of the pocket protein pathway, therefore, is the
cytes were identi®ed using MF20 antibody to sarcomeric MHCability of mammalian E2F to reproduce the phenotype pro-
(Bader et al., 1982) and rhodamine-conjugated sheep anti-mouse
voked by E1A. Five E2F transcription factors have been IgG. Live and dead cells were distinguished using calcein acetoxy-
identi®ed, together with dimerization partners DP1 and methyl ester and ethidium homodimer-1, respectively (Molecular
DP2 (Sardet et al., 1995; Wu et al., 1995). Recent reports Probes) (Kirshenbaum and Schneider, 1995).
indicate the potential for E2F-1 to override growth inhibi- DNA content. Neonatal ventricular myocytes were harvested
tion (Johnson et al., 1993) and trigger p53-dependent 48 hr after infection in 500 ml of 150 mM NaCl, 10 mM Na2HPO4,
apoptosis (Shan and Lee, 1994). Little information is avail- pH 7.4, 10 mM EDTA. Cells were centrifuged in 1.5-ml tubes for
10 min at 13,000g, resuspended in 150 ml, streaked onto glass slides,able, however, regarding the ability of E2F to regulate differ-
and allowed to air dry for 5 min. Cells were ®xed in 10% formalde-entiated gene transcription, in any lineage. In the present
hyde for 30 min, washed, and air-dried. For Feulgen staining ofreport, we have used adenoviral gene transfer to force the
cardiac nuclei, slides were incubated in 5 N HCl for 60 min, fol-expression of E2F-1 in neonatal ventricular myocytes. E2F-
lowed by 1.0% Feulgen stain in 0.1 N HCl for 60 min. Slides were1 suf®ces to produce all effects observed with E1A, thus far,
washed three times in 0.05 N HCl, rinsed, and placed in 70% etha-in cardiac muscleÐapoptosis relieved by E1B, reentry into
nol:0.37% HCl (v/v) for 5 min. Slides were dehydrated in 100%
S phase, and repression of cardiac-restricted promoters. ethanol, cleared in xylene, and mounted with glass cover slips.
Image analysis of Feulgen-stained nuclei was performed using CAS
200 instrumentation (Cell Analysis Systems) (Bacus and Grace,
MATERIALS AND METHODS 1987). At least 300 cardiac nuclei were examined, in two to three
replicate cultures, for each determination. Only morphologically
intact nuclei were scored. Normal rat liver was used as the internalCell culture and transfection. Ventricular myocytes from 2-
control (at least 20 hepatocytes per experiment) for calibration ofday postnatal Sprague±Dawley rats were puri®ed and cultured as
DNA content.described (Abdellatif et al., 1994; Brand et al., 1993; Kirshenbaum
Terminal transferase-mediated dUTP-biotin nick end-labelingand Schneider, 1995). After overnight incubation in medium con-
(TUNEL) assay. To visualize apoptotic nuclei in authenticatedtaining 5% horse serum, the medium was replaced by serum-free
cardiac myocytes, ventricular muscle cells were identi®ed by indi-medium (Kirshenbaum and Schneider, 1995). Cells infected with
rect immuno¯uorescence microscopy for sarcomeric MHC, asrecombinant adenovirus, as detailed below, were transfected imme-
above, after 48 hr in the absence or presence of the recombinantdiately after removal of viral stocks. Cells were incubated for 1 hr
viruses and were subjected to the TUNEL reaction (Gavrieli et al.,with DEAE±dextran, 2.5 mg of CMV b-gal, 5 mg of a luciferase
1992). Myocytes were incubated for 1 hr at 377C in 30 mM Tris±reporter gene, and 2.5% calf serum, and then were incubated for
HCl, pH 7.2, 140 mM sodium cacodylate, 1 mM cobalt chloride,60 sec with 10% dimethylsulfoxide in DMEM (Abdellatif et al.,
50 units of terminal deoxynucleotide transferase, and 1 nmol of1994; Brand et al., 1993; Kirshenbaum and Schneider, 1995). Cells
maintained in serum-free medium were harvested 48 hr after trans- ¯uorescein-conjugated dUTP (Boehringer Mannheim).
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Western blot analysis. For immunodetection of exogenous and E2F-1 virus in the presence or absence of E1B, and then
endogenous proteins after adenoviral gene transfer, cardiac myo- were stained with calcein acetoxymethyl ester and ethid-
cytes were harvested 48 hr after infection in 1.0% NP-40, 0.1% ium homodimer-1 (Figs. 1A±1C; Fig. 2A). After 24 hr in the
sodium dodecyl sulfate, 150 mM NaCl, 50 mM Tris±HCl, pH 7.4. absence of E1B, E2F-1 increased cell death fourfold com-
Lysates (25 mg/lane) were resolved on a 12% sodium dodecyl sul- pared to uninfected cells (P 0.05), as shown for E1A (Kirsh-
fate±polyacrylamide gel at 150 V for 1 hr and electrophoretically
enbaum and Schneider, 1995). Cells infected with E2F-1 /transferred to nitrocellulose. For E2F-1, the ®lter was incubated for
E1B or E1B alone did not differ signi®cantly from control2 hr at room temperature with rabbit antibody directed against E2F
cells. To demonstrate nuclear fragmentation in cardiac myo-(0.1 mg/ml; Santa Cruz) in 150 mM NaCl, 50 mM Tris±HCl, pH
cytes, we utilized indirect immuno¯uorescence for sarco-7.4, 0.3% Tween 20, 1.0% bovine serum albumin, followed by 0.5
mg/ml horseradish peroxidase-conjugated donkey antibody against meric MHC, together with Hoechst dye 33258 (Figs. 1J±1R;
rabbit IgG (Amersham). For serum response factor (SRF), the ®lter Fig. 2B). Again, cells infected with E2F-1 plus E1B were
was incubated with rabbit antibody to SRF (0.1 mg/ml, Santa Cruz) identical to uninfected cells, whereas nuclear fragmentation
for 1 hr at room temperature, followed by 0.5 mg/ml horseradish was conspicuous in cardiac myocytes infected with E2F-1
peroxidase-conjugated donkey antibody against rabbit IgG (Amer- alone. Apoptosis was corroborated in E2F-1-infected myo-
sham). For proliferating cell nuclear antigen (PCNA) and cyclin A, cytes as incorporation of biotinylated dUTP using the TU-
the ®lter was incubated for 1 hr at room temperature with murine
NEL reaction and was largely prevented by E1B (Figs. 1D±antibody to PCNA or cyclin A, respectively (1.0 mg/ml, Santa Cruz),
1I; Fig. 2C). As previously demonstrated with E1A (Kirshen-followed by 0.5 mg/ml horseradish peroxidase-conjugated sheep an-
baum and Schneider, 1995), nucleosomal DNA ladderingtibody against mouse IgG (Amersham). For sarcomeric a-actins,
was induced by E2F-1, but not by E2F-1 plus E1B (notthe ®lter was incubated with M4401 antibody directed toward sar-
comeric actin (1.0 mg/ml, Sigma) (Skalli et al., 1988) for 1 hr at shown).
room temperature, followed by 0.5 mg/ml horseradish peroxidase- To ascertain whether forced expression of E2F-1 might
conjugated sheep antibody against mouse IgG (Amersham). In each impinge on cardiac-restricted gene transcription (Kirshen-
case, bound second antibody was detected as chemiluminescence baum and Schneider, 1995), promoter activity was moni-
using ECL reagents (Amersham). tored after transfection of adenovirus-infected cells (Fig. 3).
Biosynthetic labeling. To detect newly synthesized sarcomeric Using E1B to avert apoptosis, transcription of the skeletal
actin, neonatal myocytes were metabolically labeled for 4 hr (18
a-actin promoter was reduced to 0.08 { 0.02 by E2F-1 rela-or 42 hr after infection), with 100 mCi/ml [35S]methionine (Amer-
tive to uninfected cells (P  0.01) and was not suppressedsham) in methionine-free, serum-free DMEM. Myocytes were sub-
by E1B alone. Repression of the cardiac a-actin promotersequently washed twice in phosphate-buffered saline and incubated
was comparable (0.12 { 0.04 of control cells; P  0.01),in serum-free DMEM containing methionine for a further 2 hr.
To detect metabolically labeled sarcomeric actin, myocytes were while the Herpes simplex virus thymidine kinase promoter
harvested 24 or 48 hr after infection in 1.0% NP-40, 0.1% sodium was relatively resistant to E2F (0.72{ 0.26, not signi®cantly
dodecyl sulfate, 150 mM NaCl, 50 mM Tris±HCl, pH 7.4. Lysates different from uninfected cells).
(100 mg) were incubated with 1 mg/ml of M4401 antibody to sarco- To examine the potential impact of E2F-1 on endogenous
meric actin overnight at 47C. Immune complexes were precipitated gene products, adenovirus-infected cells were subjected to
for 1 hr at 47C with 20 ml of protein A-G beads (Santa Cruz), washed
Western analysis (Fig. 4A). Sarcomeric a-actin (cardiac plustwice, resuspended, and resolved by sodium dodecyl sulfate ±poly-
skeletal, detected using a well-characterized monoclonalacrylamide gel electrophoresis. Proteins were electrophoretically
antibody) (Skalli et al., 1988) was not found to be down-transferred to nitrocellulose and detected by exposure to Hyper®lm
regulated 48 hr after infection; this is attributed to the long(Amersham) for 24 hr.
half-life for the protein, previously shown to be 60 hr in
cultured neonatal rat cardiac myocytes (Sharp et al., 1993).
Consequently, an array of shorter-lived proteins was tested.RESULTS
E2F-1/ E1B markedly reduced the abundance of SRF, which
is crucial for transcription of both sarcomeric a-actins inTo establish whether E2F-1 might provoke cardiac myo-
cardiac muscle (MacLellan et al., 1994; Moss et al., 1994;cyte death (Kirshenbaum and Schneider, 1995) and to ascer-
Sartorelli et al., 1992) and now is known to be expressedtain whether E1B could avert E2F-dependent apoptosis in
cardiac cells, ventricular myocytes were infected with the preferentially in cardiac and skeletal myocytes (Croissant
FIG. 1. E2F-1 provokes widespread cell death in ventricular muscle cells, through an E1B-inhibited pathway. (A, D, G, J, M, P) Control,
uninfected cells; (B, E, H, K, N, Q) E2F-1; (C, F, I, L, O, R) E2F-1 / E1B. (A±C) Cells were visualized 24 hr after infection using calcein
acetoxymethyl ester (green) and ethidium homodimer-1 (red). (D±I) Apoptosis in ventricular muscle cells was detected using the nick
end-labeling method (green) and indirect immuno¯uorescence for sarcomeric MHC (MF20 antibody, red). (J±R) Nuclear fragmentation in
ventricular muscle cells was detected using Hoechst dye 33258 and indirect immuno¯uorescence for sarcomeric MHC. Bar, 40 mm (A±
C); 10 mm (D±R).
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et al., 1996). By contrast, E2F-1/ E1B resulted in up-regula- comparable in abundance and nuclear localization (not
shown).tion of at least two cell cycle regulatorsÐcyclin A and
PCNA. To test the inference that discordance between re- E2F-1 / E1B provoked a corresponding increase in DNA
synthesis, with accumulation in G2/M predominating (Fig.pression of the sarcomeric a-actin reporter genes and the
unchanged abundance of endogenous a-actin could merely 6). Thus, E2F-1 can provoke both the onset and completion
of DNA replication in cardiac cells. The higher proportionre¯ect the proteins' stability, metabolically labeled sarco-
meric a-actin was immunoprecipitated 24 or 48 hr after of nuclei with more than diploid DNA content, compared
to the percentage of BrdU-positive cells, is expected giveninfection, and the expected down-regulation was con®rmed
(Fig. 4B). The overall pattern of [35S]methionine-labeled pro- the brief incubation with BrdU. As expected from the preva-
lent cell death produced by E2F-1 alone, a smaller propor-tein in total cell lysates was unchanged, apart from the
appearance of a 62-kDa band ascribed to E2F-1 itself (not tion of S phase and G2/M cells was seen after introducing
E2F-1 in the absence of E1B. No increase in cell numbershown).
To assess the prediction that E2F-1 could reactivate the was seen with E2F-1 or with any E1A protein, even 24 hr
after entry into G2 . Thus, E2F-1 and E1A override the G1cell cycle in ventricular muscle cells, DNA synthesis was
measured by immunoperoxidase and immuno¯uorescence checkpoint, but not the G2/M checkpoint for mitosis, in
concurrence with the role proposed for E2F-1 in certainstaining for BrdU (Figs. 5A±5I). By comparison to uninfected
cells, no increase in BrdU incorporation was seen in cultures other systems (Qin et al., 1994).
infected by either of two viruses lacking E2F-1, including
E1B alone (Figs. 5A, 5B, and 5F). Hence, the parental adeno-
viral genome, the presence of viral enhancers, or relief of DISCUSSION
p53 by E1B do not trigger DNA synthesis under these condi-
tions. Using BrdU 44 to 48 hr after infection (the time of E2F transcription factors, ®rst identi®ed as host cell pro-
teins that activate the adenovirus E2A promoter in E1A-maximal DNA synthesis induced by E1A), E2F-1 / E1B
provoked DNA synthesis in more than 50% of cells (Fig. expressing cells, now are understood to comprise at least
®ve sequence-speci®c DNA-binding proteins, which inter-5D), an ef®ciency comparable to that of wild-type 12S E1A.
E2F-1 did not require E1B for DNA synthesis, though act with the pocket domain of Rb, p107, and p130 (Wein-
berg, 1996). The principal conclusions hereÐthat forcedmarked disruption of cells is evident in the absence of E1B
(Fig. 5E). DNA synthesis in cardiac myocytes was substanti- expression of E2F-1 can reactivate DNA synthesis and re-
press lineage-restricted promoters in cardiac myocytesÐated using double immunocytochemistry (Figs. 5G±5I). As
noted previously, the prolonged half-life of sarcomeric concur with earlier mutational analysis of E1A (Kirshen-
baum and Schneider, 1995) and provide further evidenceMHC enables its use as a marker of cardiac myocyte iden-
tity despite repression of cardiac gene transcription (Kir- for operation of a pocket protein pathway in ventricular
myocytes (Field, 1988; Katz et al., 1992), a conclusion thatshenbaum and Schneider, 1995).
Because BrdU incorporation is potentially confounded by has been disputed (Liu and Kitsis, 1996). p107 and Rb are
coexpressed in neonatal myocardium (Kim et al., 1994; Tamdetection of DNA repair, we directly measured the increase
in DNA content by quantitative image analysis of Feulgen- et al., 1995), but are distinct from one another in both devel-
opmental regulation and functional consequences (Schnei-stained cardiac nuclei (Fig. 6). For uninfected cells, the pre-
dominant population (92%) possessed the expected dip- der et al., 1994). A differing outcome might therefore result
from E2F-4 or -5, which preferentially bind pocket proteinsloid content of 7 pg per nucleus. Increased DNA content
®rst was substantiated for cells infected with 12S E1A / other than Rb (Vairo et al., 1995), or from point mutations
of E2F-1, which bind differentially (Cress et al., 1993). Con-E1B and for mutations affecting either the binding site for
p300 (R2G / E1B) or pocket proteins (Y47H,C124G / E1B). versely, the fact that E2F-1 does not override p107 (Zhu et
al., 1993) and interferes with p130 only weakly (Vairo etFor each, the histograms depict a signi®cantly increased G2/
M population containing14 pg of DNA per nucleus, along al., 1995) suggests a provisional interpretation, that the phe-
notype provoked by E2F-1 in cardiac cells is dependent,with an increase in S phase cells. Shown by the increased
ploidy in cells infected with 12S E1A 0 E1B, cell cycle preferentially, on association with Rb itself.
A generic model for the function of E2F proposes thatprogression did not require E1B. Concomitant mutation of
both the p300- and pocket protein-binding sites prevented binding to pocket proteins in G0 causes repression of E2F-
dependent genes in quiescent cells (Vairo et al., 1995; Wein-reentry into S phase (R2G,C124G / E1B). Thus, cell cycle
progression required either the pocket protein- or p300- traub et al., 1992). Explanations emphasizing only levels of
free E2F may be overly simplistic in at least two respects.binding domain. The lack of a peak of hypodiploid DNA
for cells receiving E2F-1 or E1A in the absence of E1B is E2F can be complexed to distinct pocket proteins sequen-
tially as the cell cycle progress (Shin et al., 1995; Vairoattributable to the inclusion of only morphologically nor-
mal nuclei for quantitative image analysis and construction et al., 1995). Moreover, in certain cells, E2F-4 and -5 are
expressed in mid-G1 , before E2F-1 is detected (Sardet et al.,of the resulting histograms. Western analysis and immuno-
cytochemistry con®rmed that all four E1A proteins were 1995). Finally, DNA binding by E2F-1 is normally inacti-
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FIG. 3. E2F-1 represses transcription of cardiac-restricted actin
promoters. Adenovirus-infected cardiac myocytes were cotrans-
fected with the indicated luciferase reporter genes and CMV-driven
Escherichia coli lacZ. Luciferase activity corrected for lacZ (mean
{ SE) is expressed relative to that of each promoter, respectively,
in uninfected control cells. tk, Herpes simplex virus thymidine
kinase.
FIG. 2. E2F-1-induced apoptosis was monitored using (A) live±
dead staining, (B) nuclear fragmentation, and (C) nick end-labeling
as in Fig. 1. Results are the mean of duplicate cultures, scoring
more than 100 cells for each condition shown.
vated at S phase by a cyclin A±kinase complex (Krek et
al., 1995). Because E2F-induced apoptosis can preclude the
ability to test for progression beyond S phase (Qin et al.,
1994), remarkably few studies address the potential ability
of E2F proteins to trigger proliferation per se (DeGregori et
al., 1995). The available information is not suf®cient to
distinguish among several explanations for the lack of pro-
liferation produced by E2F-1 in the present studyÐan alter-
native pathway and role for E2F-1, mediating the polyploidy
or multinucleation that characterize cardiac myocytes older
than those used here; an inherent inability of postnatal car- FIG. 4. E2F-1 represses SRF expression and sarcomeric actin bio-
diac myocytes to express mitotic cyclins, the associated synthesis. (A) Cardiac myocytes were analyzed by Western blotting
kinases, or other mediators of mitosis, even in the presence 48 hr after infection with the antibodies shown. (B) Biosynthesis:
of exogenous E2F-1; potential differences, conversely, in immunoprecipitation of [35S]methionine-labeled sarcomeric actin
was performed 24 and 48 hr after infection as indicated.growth inhibitory proteins; or merely a more generalizable
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FIG. 5. E2F activates DNA synthesis in ventricular myocytes. Cells were cultured in serum-free medium, except as noted, supplemented
with 10 mM BrdU 44±48 hr after exposure to virus. (A, G) Uninfected cells; (B) control virus, AdRSVLuc (Kirshenbaum et al., 1993); (C,
I) 20% FBS as a positive control; (D, H) E2F-1 plus E1B; (E) E2F-1 without E1B; (F) E1B. (A±F) Immunoperoxidase detection of BrdU. (G±
I) Epi¯uorescence microscopy for BrdU (¯uorescein) and sarcomeric MHC (rhodamine). BrdU-positive, MHC-positive cells are seen in H
and I. Bar, 50 (A±F) or 20 (G ±I) mm.
FIG. 6. E1A and E2F-1 cause accumulation of cardiac myocytes in G2/M. Histograms indicate DNA content 48 hr after infection, by
quantitative image analysis of Feulgen-stained cardiac nuclei. No increase in cell number was seen under these conditions, even after a
further 24 hr.
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